Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding (SBB) short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which accurately detects the nucleotide sequence and epigenetic status of individual DNA molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.
企業コードPACB
会社名Pacific Biosciences of California Inc
上場日Oct 27, 2010
最高経営責任者「CEO」Mr. Christian O. Henry
従業員数575
証券種類Ordinary Share
決算期末Oct 27
本社所在地1305 O'brien Drive
都市MENLO PARK
証券取引所NASDAQ Global Select Consolidated
国United States of America
郵便番号94025
電話番号16505218000
ウェブサイトhttps://www.pacb.com/
企業コードPACB
上場日Oct 27, 2010
最高経営責任者「CEO」Mr. Christian O. Henry
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし